Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-31 @ 12:31 AM
Study NCT ID:
NCT05869669
Status:
COMPLETED
Last Update Posted:
2025-07-18
First Post:
2023-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Sponsor:
EIP Pharma Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EIP21-NFD-504
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None